A recent study found that while children exposed to benzodiazepine during pregnancy had a greater risk of developing autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), siblings without exposure saw similar risks of neurodevelopmental disorders.
The National Institutes of Health has given 8 research grants for refining new technologies to provide early diagnosis of severe illness associated with COVID-19 infection in children.
A phase 3 trial of lomitapide showed safety and efficacy for treating homozygous familial hypercholesterolemia (HoFH) in pediatric patients aged 5 to 17 years.
The February 2023 edition of Pediatrics included evidence-based guidelines from the American Academy of Pediatrics on evaluating and treating obesity in children and adolescents.
VERO Biotech Inc has announced a US Food and Drug Administration approval for the third generation of their tankless Genosyl Delivery System.
Patients with a history of multisystem inflammatory syndrome in children (MIS-C) completed a questionnaire about adverse reactions following COVID-19 vaccination, and no serious adverse events were recorded.
A recent study found that children were more likely to present with high BMI and obesity if they had low Child Opportunity Index scores early in life.
Recent research projects the prevalence of type 1 and type 2 diabetes among youths will rise through 2060.
The US Food Administration has agreed to review an application for nirsevimab (Beyfortus; AstraZeneca and Sanofi) to protect infants against RSV.
In a recent study, it was found adolescents who frequently checked social media had a lower neural sensitivity to social anticipation.
In a recent study, it was found that children with medical complexity are at a greater risk of overweight and obesity compared to children without medical complexity.
A recent review found that early diagnosis and adequate treatment is important in preventing neurodevelopmental impairments in newborns with congenital hypothyroidism
A recent study found that children were 7.5 times more likely to visit behavioral health services after positive screening for adverse childhood experiences.
Novo Nordisk has announced their product Wegovy received approval from the US Food and Drug Administration for use in adolescents aged 12 years and older with obesity.
We revisit some of last year’s top articles about autism spectrum disorder.
At the end of 2022, we revisit some of this year’s top articles.
In a recent trial, children aged 6 to 13 with vitamin D deficiency did not see influence on linear growth, body composition, or pubertal development when taking vitamin D supplements.
A look at what the Contemporary Pediatrics® team covered this week.
The American Academy of Pediatrics has updated their report, “Exploitation, Labor and Sex Trafficking of Children and Adolescents: Health Care Needs of Patients,” to provide updated guidance on how physicians can recognize and help children and adolescents subjected to trafficking or exploitation.
The American Academy of Pediatrics has provided 10 tips parents and guardians can utilize to keep their children warm and safe outdoors this winter.
In a recent study, it was found that obesity is not present in all cases of type 2 diabetes in pediatric patients.
The CDC has reported an increase in drug overdose deaths from 2019 to 2022 in adolescents aged 10 to 19 years.
In a recent Mott Poll, parents discussed their beliefs on how children aged 13 to 18 years benefit from religious services, how often these children should participate, and the level of freedom they would give their children to choose whether to participate.
In a recent report, the American Academy of Pediatrics outlined steps parents and pediatricians can take to prevent tooth decay in pediatric patients.
Arcutis Biotherapeutics, Inc has submitted a supplemental New Drug Application for roflumilast cream (ZORYVE) to the US Food and Drug Administration for treatment of plaque psoriasis in children aged 2 to 11 years.
When comparing the rate of diagnoses for autism spectrum disorder given clinically to those given through the Autism Diagnostic Observation Schedule (ADOS), consistency between the 2 methods was found.
After the Antenatal Late Preterm Steroid (ALPS) trial showed a decrease in respiratory complications following steroid administration, steroid exposure among newborns increased.
In a recent study, parents who reported frequently giving their children mobile devices for calming purposes reported increased emotional activity and temperamental surgency in their children.
In a recent study, it was found that lumbar punctures are not as common for late-onset sepsis, potentially leading to an underestimated figure when measuring cases and outcomes of late-onset meningitis.
The FDA has approved atezolizumab for use in patients aged 2 years and older with unresectable or metastatic alveolar soft part sarcoma.
